Inhaled corticosteroids reduce asthma-associated airway hyperperfusion through genomic and nongenomic mechanisms

Gabor Horvath, Szilvia Vasas, Adam Wanner

Open source

DOI
10.1016/j.pupt.2006.03.009
Published
2007-04
Container
Pulmonary Pharmacology & Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pupt.2006.03.009,
  title = {Inhaled corticosteroids reduce asthma-associated airway hyperperfusion through genomic and nongenomic mechanisms},
  author = {Gabor Horvath and Szilvia Vasas and Adam Wanner},
  year = {2007},
  journal = {Pulmonary Pharmacology \& Therapeutics},
  doi = {10.1016/j.pupt.2006.03.009},
  url = {https://doi.org/10.1016/j.pupt.2006.03.009}
}

RIS

TY  - JOUR
TI  - Inhaled corticosteroids reduce asthma-associated airway hyperperfusion through genomic and nongenomic mechanisms
AU  - Gabor Horvath
AU  - Szilvia Vasas
AU  - Adam Wanner
PY  - 2007
JO  - Pulmonary Pharmacology & Therapeutics
DO  - 10.1016/j.pupt.2006.03.009
UR  - https://doi.org/10.1016/j.pupt.2006.03.009
ER  - 

APA

Horvath, G., Vasas, S., & Wanner, A. (2007). Inhaled corticosteroids reduce asthma-associated airway hyperperfusion through genomic and nongenomic mechanisms. Pulmonary Pharmacology & Therapeutics. https://doi.org/10.1016/j.pupt.2006.03.009

Source records